The 2012 Diabetes Technology Meeting provides new insights into the artificial pancreas and the latest thinking on regulation from the FDA.

The artificial pancreas in peoples’ homes at the Annual Technologies & Treatments for Diabetes Meeting in Paris.

In late June, diaTribe sent our team to Chicago to attend the 67th Annual Scientific Sessions of the American Diabetes Association.

Main themes from AACE.

Click to learn exciting news on the artificial pancreas, faster insulins, and the results of the much-anticipated ORIGIN trial.

Our trip to Orlando brings smart, actionable advice on preventing high and low blood sugars from diabetes guru and educator Mr. Gary Scheiner.

The 30th Annual Obesity Society Meeting brings exciting insights on drugs and mobile health.

What do Michelle Obama, soda, and cities have in common? Our top five patient takeaways from PHA this year.

Five key insights from April’s big-deal artificial pancreas meeting in Washington, DC.

The evolving field of type 1 diabetes and how research should improve to get closer to finding a cure.

What it felt like to forget about diabetes for a week.

At ADA this year, type 2 drugs for type 1 diabetes show lots of promise. Plus, the latest exciting data on the Medtronic Veo and hypoglycemia.

A whole new approach to treating type 2 diabetes at diagnosis, a new type of metformin, and the benefit of adding a GLP-1 agonist to insulin.

Can more type 2 therapies be used for type 1 diabetes?

The FDA impresses us at The Diabetes Mine Innovation Summit. Plus, sleek new software for downloading data to the cloud.

A game-changing therapy for type 2 diabetes? Plus, the latest on predictive low glucose suspend, faster insulin, and a better Bydureon.

This year at ADA, the science was exciting as always, but what really made us happy was the deep focus on patient perspectives.

Advances for type 2 diabetes at The American Diabetes Association 74th Scientific Sessions

Advances in type 1 diabetes at The American Diabetes Association 74th Scientific Sessions

What can you do right now to advance diabetes advocacy? A summary from an insightful day at Masterlab.